Geron Corp (GERN)
3.725
-0.08
(-2.23%)
USD |
NASDAQ |
May 20, 16:00
3.725
0.00 (0.00%)
After-Hours: 20:00
Geron Price to Book Value: 6.407 for May 20, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 6.553 |
| May 16, 2024 | 6.708 |
| May 15, 2024 | 6.708 |
| May 14, 2024 | 6.329 |
| May 13, 2024 | 6.432 |
| May 10, 2024 | 6.536 |
| May 09, 2024 | 6.673 |
| May 08, 2024 | 6.553 |
| May 07, 2024 | 6.656 |
| May 06, 2024 | 6.415 |
| May 03, 2024 | 6.759 |
| May 02, 2024 | 6.794 |
| May 01, 2024 | 7.017 |
| April 30, 2024 | 6.759 |
| April 29, 2024 | 7.120 |
| April 26, 2024 | 6.518 |
| April 25, 2024 | 6.102 |
| April 24, 2024 | 6.137 |
| April 23, 2024 | 6.000 |
| April 22, 2024 | 6.394 |
| April 19, 2024 | 6.325 |
| April 18, 2024 | 6.394 |
| April 17, 2024 | 6.308 |
| April 16, 2024 | 6.137 |
| April 15, 2024 | 5.914 |
| Date | Value |
|---|---|
| April 12, 2024 | 6.240 |
| April 11, 2024 | 6.462 |
| April 10, 2024 | 5.897 |
| April 09, 2024 | 5.880 |
| April 08, 2024 | 5.708 |
| April 05, 2024 | 5.691 |
| April 04, 2024 | 5.502 |
| April 03, 2024 | 5.502 |
| April 02, 2024 | 5.314 |
| April 01, 2024 | 5.434 |
| March 31, 2024 | |
| March 28, 2024 | 7.837 |
| March 27, 2024 | 7.861 |
| March 26, 2024 | 7.837 |
| March 25, 2024 | 7.742 |
| March 22, 2024 | 7.861 |
| March 21, 2024 | 7.909 |
| March 20, 2024 | 7.587 |
| March 19, 2024 | 7.190 |
| March 18, 2024 | 7.003 |
| March 15, 2024 | 7.411 |
| March 14, 2024 | 3.860 |
| March 13, 2024 | 3.860 |
| March 12, 2024 | 4.146 |
| March 11, 2024 | 4.714 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.315
Minimum
Mar 18 2020
19.09
Maximum
Jan 24 2023
4.190
Average
2.930
Median
Feb 17 2021
Price to Book Value Benchmarks
| Madrigal Pharmaceuticals Inc | 5.816 |
| SELLAS Life Sciences Group Inc | 8.797 |
| Johnson & Johnson | 5.202 |
| Pfizer Inc | 1.752 |
| Immuneering Corp | 0.5575 |
Price to Book Value Related Metrics
| PS Ratio | 4164.71 |
| PEG Ratio | -3.619 |
| Price | 3.725 |
| Earnings Yield | -9.40% |
| Market Cap | 2.209B |
| PEGY Ratio | -3.619 |